Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
6.7(c) 6.65(c) 6.825(c) 6.96(c) 6.77(c) Last
167 878 222 305 263 727 113 453 153 628 Volume
-2.76% -0.75% +2.63% +1.98% -2.73% Change
More quotes
Company
Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company. It is focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies. Prostones, naturally occurring fatty acid metabolites that have emerged as... 
Sector
Biotechnology
Calendar
05/06Earnings Release
Surperformance© rating of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 110 M
EBIT 2014 23,5 M
Net income 2014 16,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 136 M
EBIT 2015 40,2 M
Net income 2015 29,4 M
Debt 2015 -
Yield 2015 -
PER 2014 17,20
PER 2015 10,35
Capi. / Sales 2014 2,70x
Capi. / Sales 2015 2,20x
Capitalization 298 M
More Financials
Latest news on SUCAMPO PHARMACEUTICALS, I
04/08 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
03/25 SUCAMPO PHARMACEUTICALS : Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to R..
03/21 SUCAMPO PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
03/14 Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(..
03/12 SUCAMPO PHARMACEUTICALS : DGAP-News: Sucampo Receives Notice that Second Indicat..
03/12 SUCAMPO PHARMACEUTICALS : Receives Notice that Second Indication for AMITIZA for..
03/05 SUCAMPO PHARMACEUTICALS, INC. : Sucampo Pharmaceuticals Announces Webcast of Its..
03/04 SUCAMPO PHARMACEUTICALS, INC. : Sucampo and National Cherry Blossom Festival Ann..
02/26 SUCAMPO PHARMACEUTICALS, INC. : FILES (8-K) Disclosing Results of Operations and..
02/26 SUCAMPO PHARMACEUTICALS, INC. : Reports Fourth Quarter and Full Year 2013 Financ..
02/14 SUCAMPO PHARMACEUTICALS, INC. : FILES (8-K/A) Disclosing Regulation FD Disclosur..
02/12 SUCAMPO PHARMACEUTICALS, INC. : FILES (8-K) Disclosing Change in Directors or Pr..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Sucampo Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Sucampo Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF